These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 71663)
21. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. Khoury SJ; Sayegh MH; Hancock WW; Gallon L; Carpenter CB; Weiner HL J Exp Med; 1993 Aug; 178(2):559-66. PubMed ID: 7688026 [TBL] [Abstract][Full Text] [Related]
22. Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis. Robin JB; Phillips TM; Rao NA Ophthalmic Res; 1985; 17(3):174-80. PubMed ID: 2409498 [TBL] [Abstract][Full Text] [Related]
23. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. Saoudi A; Simmonds S; Huitinga I; Mason D J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135 [TBL] [Abstract][Full Text] [Related]
24. The spinal cord protein (SCP): appraisal of physiological and immunological hypotheses of anti-encephalitogenic action. MacPherson CF Immunochemistry; 1978 Nov; 15(10-11):767-75. PubMed ID: 85602 [No Abstract] [Full Text] [Related]
25. Maintenance of immunologic self-tolerance by nonimmunogenic forms of antigen. Swanborg RH Clin Exp Immunol; 1976 Dec; 26(3):597-600. PubMed ID: 64328 [TBL] [Abstract][Full Text] [Related]
26. Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats. Kasarello K; Kwiatkowska-Patzer B; Lipkowski AW; Bardowski JK; Szczepankowska AK Med Sci Monit; 2015 May; 21():1587-97. PubMed ID: 26026273 [TBL] [Abstract][Full Text] [Related]
27. The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis. Mokhtarian F; Shirazian T; Batuman O; Shi Y Ann N Y Acad Sci; 1996 Feb; 778():414-7. PubMed ID: 8611007 [No Abstract] [Full Text] [Related]
28. Immunomodulation of experimental allergic encephalomyelitis. Arnon R; Teitelbaum D Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204 [No Abstract] [Full Text] [Related]
29. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968 [TBL] [Abstract][Full Text] [Related]
30. Transfer of experimental allergic encephalomyelitis with guinea pig peritoneal exudate cells. Driscoll BF; Kies MW; Alvord EC Science; 1979 Feb; 203(4380):547-8. PubMed ID: 83676 [TBL] [Abstract][Full Text] [Related]
31. Modulation of adoptive cell transfers in experimental allergic encephalomyelitis by antigen treatment of donors. Rauch HC Cell Immunol; 1981 May; 60(1):220-7. PubMed ID: 6165484 [No Abstract] [Full Text] [Related]
32. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants. Wall M; Southwood S; Sidney J; Oseroff C; del Guericio MF; Lamont AG; Colón SM; Arrhenius T; Gaeta FC; Sette A Int Immunol; 1992 Jul; 4(7):773-7. PubMed ID: 1379827 [TBL] [Abstract][Full Text] [Related]
33. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats. Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171 [TBL] [Abstract][Full Text] [Related]
35. Partial characterization of the human anti-encephalitogenic protein: isolation from spinal cord and spinal nerves. Weir KG; MacPherson CF Biochim Biophys Acta; 1978 Feb; 532(2):232-41. PubMed ID: 75025 [No Abstract] [Full Text] [Related]
38. The encephalitogenic dose response in guinea pigs of the tryptophan region of myelin basic protein. Young JD; Tsuchiya D; Geier M; Geier S; Westall FC; Thompson M; Cyr R; Ward E; Yurochko F Immunol Commun; 1974; 3(3):219-26. PubMed ID: 4137974 [No Abstract] [Full Text] [Related]
39. Cytotoxic T cells in autoimmune disease of the central nervous system. Sun D; Meyermann R; Wekerle H Ann N Y Acad Sci; 1988; 532():221-9. PubMed ID: 2460009 [No Abstract] [Full Text] [Related]
40. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. Ufret-Vincenty RL; Quigley L; Tresser N; Pak SH; Gado A; Hausmann S; Wucherpfennig KW; Brocke S J Exp Med; 1998 Nov; 188(9):1725-38. PubMed ID: 9802984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]